Translational studies on regulation of brain docosahexaenoic acid (DHA) metabolism in vivo

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 88, Issue 1, 2013, Pages 79-85

  Rapoport, Stanley I ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CALCIUM INDEPENDENT PHOSPHOLIPASE A2; CALCIUM INDEPENDENT PHOSPHOLIPASE A2 BETA; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; LINOLENIC ACID; PHOSPHOLIPID; TRACER; UNCLASSIFIED DRUG;

ARTICLE; BRAIN LEVEL; BRAIN METABOLISM; DIETARY INTAKE; ESSENTIAL FATTY ACID DEFICIENCY; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; FATTY ACID TRANSPORT; HALF LIFE TIME; HUMAN; IN VIVO STUDY; ISOTOPE LABELING; METABOLIC REGULATION; NEUROIMAGING; NEUROTRANSMISSION; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TRANSLATIONAL RESEARCH;

ANIMALS; BIOLOGICAL MARKERS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN; BRAIN MAPPING; DOCOSAHEXAENOIC ACIDS; FATTY ACIDS, NONESTERIFIED; HUMANS; KINETICS; NEURONS; PHOSPHOLIPASES A2; PHOSPHOLIPIDS; TRANSLATIONAL MEDICAL RESEARCH;

ANIMALIA; RATTUS; RODENTIA;

EID: 84872043499     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2012.05.003     Document Type: Article

References (81)

1. Piomelli D., Astarita G., Rapaka R. A neuroscientist's guide to lipidomics. Nat. Rev. Neurosci. 2007, 8:743-754.
2. Niemoller T.D., Bazan N.G. Docosahexaenoic acid neurolipidomics. Prostaglandins Other Lipid Mediat 2010, 91:85-89.
3. Kurian M.A., Morgan N.V., MacPherson L., Foster K., Peake D., Gupta R., Philip S.G., Hendriksz C., Morton J.E., Kingston H.M., Rosser E.M., Wassmer E., Gissen P., Maher E.R. Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G6 gene (PLAN). Neurology 2008, 70:1623-1629.
4. Meira-Lima I., Jardim D., Junqueira R., Ikenaga E., Vallada H. Allelic association study between phospholipase A2 genes and bipolar affective disorder. Bipolar Disord. 2003, 5:295-299.
5. Morgan N.V., Westaway S.K., Morton J.E., Gregory A., Gissen P., Sonek S., Cangul H., Coryell J., Canham N., Nardocci N., Zorzi G., Pasha S., Rodriguez D., Desguerre I., Mubaidin A., Bertini E., Trembath R.C., Simonati A., Schanen C., Johnson C.A., Levinson B., Woods C.G., Wilmot B., Kramer P., Gitschier J., Maher E.R., Hayflick S.J. PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron. Nat. Genet. 2006, 38:752-754.
6. Salem N., Litman B., Kim H.Y., Gawrisch K. Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids 2001, 36:945-959.
7. Serhan C.N., Gotlinger K., Hong S., Arita M. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis. Prostaglandins Other Lipid Mediat. 2004, 73:155-172.
8. Bazan N.G. Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection. Curr. Opin. Clin. Nutr. Metab. Care 2007, 10:136-141.
9. Gao F., Kiesewetter D., Chang L., Ma K., Rapoport S.I., Igarashi M. Whole-body synthesis-secretion of docosahexaenoic acid from circulating Eicosapentaenoic acid in anesthetized rats. J. Lipid Res. 2009, 50:2463-2470.
10. Rapoport S.I., Igarashi M., Gao F. Quantitative contributions of diet and liver synthesis to docosahexaenoic acid homeostasis. Prostaglandins Leukot. Essent. Fatty Acids 2010, 82:273-276.
11. Gao F., Kim H.W., Igarashi M., Kiesewetter D., Chang L., Ma K., Rapoport S.I. Liver conversion of docosahexaenoic and arachidonic acids from their 18-carbon precursors in rats on a DHA-free but alpha-LNA-containing n-3 PUFA adequate diet. Biochim. Biophys. Acta 2011, 1811:484-489.
12. McNamara R.K., Jandacek R., Rider T., Tso P., Dwivedi Y., Pandey G.N. Selective deficits in erythrocyte docosahexaenoic acid composition in adult patients with bipolar disorder and major depressive disorder. Journal of Affective Disorders 2010, 126:303-311.
13. McNamara R.K., Jandacek R., Rider T., Tso P., Stanford K.E., Hahn C.G., Richtand N.M. Deficits in docosahexaenoic acid and associated elevations in the metabolism of arachidonic acid and saturated fatty acids in the postmortem orbitofrontal cortex of patients with bipolar disorder. Psychiatry Res. 2008, 160:285-299.
14. Conquer J.A., Tierney M.C., Zecevic J., Bettger W.J., Fisher R.H. Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment. Lipids 2000, 35:1305-1312.
15. Lukiw W.J., Bazan N.G. Neuroinflammatory signaling upregulation in Alzheimer's disease. Neurochem. Res. 2000, 25:1173-1184.
16. Greiner R.S., Moriguchi T., Slotnick B.M., Hutton A., Salem N. Olfactory discrimination deficits in n-3 fatty acid-deficient rats. Physiol. Behav. 2001, 72:379-385.
17. Demar J.C., Ma K., Bell J.M., Igarashi M., Greenstein D., Rapoport S.I. One generation of n-3 polyunsaturated fatty acid deprivation increases depression and aggression test scores in rats. J Lipid Res. 2006, 47:172-180.
18. Quinn J.F., Raman R., Thomas R.G., Yurko-Mauro K., Nelson E.B., Van Dyck C., Galvin J.E., Emond J., Jack C.R., Weiner M., Shinto L., Aisen P.S. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA 2010, 304:1903-1911.
19. Sarris J., Mischoulon D., Schweitzer I. Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression. J. Clin. Psychiatry 2011.
20. Igarashi M., Ma K., Gao F., Kim H.W., Greenstein D., Rapoport S.I., Rao J.S. Brain lipid concentrations in bipolar disorder. J. Psychiatric Res. 2010, 44:177-182.
21. Igarashi M., Ma K., Gao F., Kim H.W., Rapoport S.I., Rao J.S. Disturbed choline plasmalogen and phospholipid fatty acid concentrations in Alzheimer's disease prefrontal cortex. JAD 2011, 24:507-517.
22. Kim H.W., Rao J.S., Rapoport S.I., Igarashi M. Regulation of rat brain polyunsaturated fatty acid (PUFA) metabolism during graded dietary n-3 PUFA deprivation. Prostaglandins Leukot. Essent. Fatty Acids 2011, 85:361-368.
23. Bourre J.M., Francois M., Youyou A., Dumont O., Piciotti M., Pascal G., Durand G. The effects of dietary alpha-linolenic acid on the composition of nerve membranes, enzymatic activity, amplitude of electrophysiological parameters, resistance to poisons and performance of learning tasks in rats. J. Nutr. 1989, 119:1880-1892.
24. Bourre J.M., Dumont O., Pascal G., Durand G. Dietary alpha-linolenic acid at 1.3g/kg maintains maximal docosahexaenoic acid concentration in brain, heart and liver of adult rats. J. Nutr. 1993, 123:1313-1319.
25. Wang Y., Botolin D., Xu J., Christian B., Mitchell E., Jayaprakasam B., Nair M.G., Peters J.M., Busik J.V., Olson L.K., Jump D.B. Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity. J. Lipid Res. 2006, 47:2028-2041.
26. Rapoport S.I., Ramadan E., Basselin M. Docosahexaenoic acid (DHA) incorporation into the brain from plasma, as an in vivo biomarker of brain DHA metabolism and neurotransmission. Prostaglandins Other Lipid Mediat. 2011, 96:109-113.
27. Rosell M.S., Lloyd-Wright Z., Appleby P.N., Sanders T.A., Allen N.E., Key T.J. Long-chain n-3 polyunsaturated fatty acids in plasma in British meat-eating, vegetarian, and vegan men. Am. J. Clin. Nutr. 2005, 82:327-334.
28. Key T.J., Appleby P.N., Spencer E.A., Travis R.C., Roddam A.W., Allen N.E. Mortality in British vegetarians: results from the European Prospective Investigation into Cancer and Nutrition (EPIC-Oxford). Am. J. Clin. Nutr. 2009, 89:1613S-1619S.
29. Bazan N.G. Cellular and molecular events mediated by docosahexaenoic acid-derived neuroprotectin D1 signaling in photoreceptor cell survival and brain protection. Prostaglandins Leukot. Essent. Fatty Acids 2009, 81:205-211.
30. DeMar J.C., Ma K., Bell J.M., Rapoport S.I. Half-lives of docosahexaenoic acid in rat brain phospholipids are prolonged by 15 weeks of nutritional deprivation of n-3 polyunsaturated fatty acids. J. Neurochem. 2004, 91:1125-1137.
31. Lands W.E.M., Crawford C.G. Enzymes of membrane phospholipid metabolism. The Enzymes of Biological Membranes 1976, 2:3-85. Plenum, New York.
32. Sun G.Y., MacQuarrie R.A. Deacylation-reacylation of arachidonoyl groups in cerebral phospholipids. Ann. N Y Acad. Sci. 1989, 559:37-55.
33. Robinson P.J., Noronha J., DeGeorge J.J., Freed L.M., Nariai T., Rapoport S.I. A quantitative method for measuring regional in vivo fatty-acid incorporation into and turnover within brain phospholipids: Review and critical analysis. Brain Res. Rev. 1992, 17:187-214.
34. Rapoport S.I. In vivo fatty acid incorporation into brain phospholipids in relation to plasma availability, signal transduction and membrane remodeling, J. Mol. Neuroscience 2001, 16:243-261.
35. Igarashi M., Kim H.W., Chang L., Ma K., Rapoport S.I. Dietary N-6 polyunsaturated fatty acid deprivation increases docosahexaenoic acid metabolism in rat brain. J. Neurochem. 2011.
36. Igarashi M., Kim H.W., Gao F., Chang L., Ma K., Rapoport S.I. Fifteen weeks of dietary n-3 polyunsaturated fatty acid deprivation increase turnover of n-6 docosapentaenoic acid in rat-brain phospholipids. Biochim. Biophys. Acta 2011.
37. Umhau J.C., Zhou W., Carson R.E., Rapoport S.I., Polozova A., Demar J., Hussein N., Bhattacharjee A.K., Ma K., Esposito G., Majchrzak S., Herscovitch P., Eckelman W.C., Kurdziel K.A., Salem N. Imaging incorporation of circulating docosahexaenoic acid into the human brain using positron emission tomography. J. Lipid Res. 2009, 50:1259-1268.
38. Esposito G., Giovacchini G., Der M., Liow J.S., Bhattacharjee A.K., Ma K., Herscovitch P., Channing M., Eckelman W.C., Hallett M., Carson R.E., Rapoport S.I. Imaging signal transduction via arachidonic acid in the human brain during visual stimulation, by means of positron emission tomography. Neuroimage 2007, 34:1342-1351.
39. Thambisetty M., Gallardo K.A., Liow J.S., Beason-Held L.L., Umhau J.C., Bhattacharjee A.K., Der M., Herscovitch P., Rapoport J.L., Rapoport S.I. The utility of (11)C-arachidonate PET to study in vivo dopaminergic neurotransmission in humans. J. Cereb. Blood Flow. Metab. 2011.
40. Holman R.T. Control of polyunsaturated acids in tissue lipids. J. Am. Coll. Nutr. 1986, 5:183-211.
41. Purdon D., Arai T., Rapoport S. No evidence for direct incorporation of esterified palmitic acid from plasma into brain lipids of awake adult rat. J. Lipid Res. 1997, 38:526-530.
42. Chen C.T., Ma D.W., Kim J.H., Mount H.T., Bazinet R.P. The low density lipoprotein receptor is not necessary for maintaining mouse brain polyunsaturated fatty acid concentrations. J. Lipid Res. 2008, 49:147-152.
43. Gavino G.R., Gavino V.C. Rat liver outer mitochondrial carnitine palmitoyltransferase activity towards long-chain polyunsaturated fatty acids and their CoA esters. Lipids 1991, 26:266-270.
44. DeGeorge J.J., Nariai T., Yamazaki S., Williams W.M., Rapoport S.I. Arecoline-stimulated brain incorporation of intravenously administered fatty acids in unanesthetized rats. J. Neurochem. 1991, 56:352-355.
45. 14C]arachidonate to examine regional brain lipid metabolism in unanesthetized rats. J. Neurosci. Res. 1989, 24:413-423.
46. Chen C.T., Liu Z., Bazinet R.P. Rapid de-esterification and loss of eicosapentaenoic acid from rat brain phospholipids: an intracerebroventricular study. J. Neurochem. 2011, 116:363-373.
47. Demar J.C., Ma K., Chang L., Bell J.M., Rapoport S.I. alpha-Linolenic acid does not contribute appreciably to docosahexaenoic acid within brain phospholipids of adult rats fed a diet enriched in docosahexaenoic acid. J. Neurochem. 2005, 94:1063-1076.
48. M. Igarashi, J.C. Demar, Jr., K. Ma, L. Chang, J.M. Bell, S.I. Rapoport, Rate of synthesis of docosahexaenoic acid from alpha -linolenic acid by rat brain is not altered by dietary N-3 polyunsaturated fatty acid deprivation, J. Lipid Res., (2007).
49. Igarashi M., Demar J.C., Ma K., Chang L., Bell J.M., Rapoport S.I. Upregulated liver conversion of {alpha}-linolenic acid to docosahexaenoic acid in rats on a 15 week n-3 PUFA-deficient diet. J. Lipid Res. 2007, 48:152-164.
50. Basselin M., Ramadan E., Rapoport S.I. Imaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans. Brain Res. Bull. 2011.
51. Deutsch J., Rapoport S.I., Purdon A.D. Relation between free fatty acid and acyl-CoA concentrations in rat brain following decapitation. Neurochem. Res. 1997, 22:759-765.
52. Shetty H.U., Smith Q.R., Washizaki K., Rapoport S.I., Purdon A.D. Identification of two molecular species of rat brain phosphatidylcholine that rapidly incorporate and turn over arachidonic acid in vivo. J. Neurochem. 1996, 67:1702-1710.
53. Contreras M.A., Greiner R.S., Chang M.C.J., Myers C.S., Bell J.M., Salem N., Rapoport S.I. Alpha-linolenic acid deprivation alters the in vivo turnover of docosahexaenoic acid in rat brain phospholipids. J. Neurochem. 1999, 72:S65D.
54. Chang M.C.J., Grange E., Rabin O., Bell J.M., Allen D.D., Rapoport S.I. Lithium decreases turnover of arachidonate in several brain phospholipids. Neurosci. Lett. 1996, 220:171-174.
55. Rapoport S.I., Bosetti F. Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder?. Arch. Gen. Psychiatry 2002, 59:592-596.
56. Rapoport S.I., Basselin M., Kim H.W., Rao J.S. Bipolar disorder and mechanisms of action of mood stabilizers. Brain Res. Rev. 2009, 61:185-209.
57. Rapoport S.I. Brain arachidonic and docosahexaenoic acid cascades are selectively altered by drugs, diet and disease. Prostaglandins Leukot. Essent. Fatty Acids 2008, 79:153-156.
58. Yau T.M., Sun G.Y. The metabolism of (1-14C)arachidonic acid in the neutral glycerides and phosphoglycerides of mouse brain. J. Neurochem. 1974, 23:99-104.
59. Stinson A.M., Wiegand R.D., Anderson R.E. Recycling of docosahexaenoic acid in rat retinas during n-3 fatty acid deficiency. J. Lipid. Res. 1991, 32:2009-2017.
60. Rapoport S.I., Chang M.C., Spector A.A. Delivery and turnover of plasma-derived essential PUFAs in mammalian brain. J. Lipid Res. 2001, 42:678-685.
61. Qu Y., Villacreses N., Murphy D.L., Rapoport S.I. 5-HT2A/2C receptor signaling via phospholipase A2 and arachidonic acid is attenuated in mice lacking the serotonin reuptake transporter. Psychopharmacology (Berl) 2005, 180:12-20.
62. Berg K.A., Maayani S., Clarke W.P. Interactions between effectors linked to serotonin receptors. Ann. NY Acad. Sci. 1998, 861:111-120.
63. Vial D., Piomelli D. Dopamine D2 receptors potentiate arachidonate release via activation of cytosolic, arachidonate-specific phospholipase A2. J. Neurochem. 1995, 64:2765-2772.
64. 2 is coupled to muscarinic receptors in the human astrocytoma cell line 1321N1: characterization of the transducing mechanism. Biochem. J. 1997, 323:281-287.
65. Basselin M., Chang L., Bell J.M., Rapoport S.I. Chronic lithium chloride administration attenuates brain NMDA receptor-initiated signaling via arachidonic acid in unanesthetized rats. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2006, 31:1659-1674.
66. Garcia M.C., Kim H.Y. Mobilization of arachidonate and docosahexaenoate by stimulation of the 5-HT2A receptor in rat C6 glioma cells. Brain Res. 1997, 768:43-48.
67. Rosa A.O., Rapoport S.I. Intracellular- and extracellular-derived Ca(2+) influence phospholipase A(2)-mediated fatty acid release from brain phospholipids. Biochim Biophys Acta 2009, 1791:697-705.
68. Ong W.Y., Yeo J.F., Ling S.F., Farooqui A.A. Distribution of calcium-independent phospholipase A2 (iPLA 2) in monkey brain. J. Neurocyt. 2005, 34:447-458.
69. Ong W.Y., Sandhya T.L., Horrocks L.A., Farooqui A.A. Distribution of cytoplasmic phospholipase A2 in the normal rat brain. J. Hirnforsch. 1999, 39:391-400.
70. Lin T.N., Wang Q., Simonyi A., Chen J.J., Cheung W.M., He Y.Y., Xu J., Sun A.Y., Hsu C.Y., Sun G.Y. Induction of secretory phospholipase A2 in reactive astrocytes in response to transient focal cerebral ischemia in the rat brain. J. Neurochem. 2004, 90:637-645.
71. Tay A., Simon J.S., Squire J., Hamel K., Jacob H.J., Skorecki K. Cytosolic phospholipase A2 gene in human and rat: chromosomal localization and polymorphic markers. Genomics 1995, 26:138-141.
72. 2 and n-3 polyunsaturated fatty acid docosahexaenoic acid in prostanoid production in brain: perspectives for protection in neuroinflammation. Int. J. Dev. Neurosci. 2004, 22:551-557.
73. Ramadan E., Rosa A.O., Chang L., Chen M., Rapoport S.I., Basselin M. Extracellular-derived calcium does not initiate in vivo neurotransmission involving docosahexaenoic acid. J. Lipid Res. 2010, 51:2334-2340.
74. Six D.A., Dennis E.A. The expanding superfamily of phospholipase A(2) enzymes: classification and characterization. Biochim. Biophys. Acta 2000, 1488:1-19.
75. Bao S., Jacobson D.A., Wohltmann M., Bohrer A., Jin W., Philipson L.H., Turk J. Glucose homeostasis, insulin secretion, and islet phospholipids in mice that overexpress iPLA2beta in pancreatic beta-cells and in iPLA2beta-null mice. Am. J. Physiol. Endocrinol. Metab. 2008, 294:E217-E229.
76. Basselin M., Rosa A.O., Ramadan E., Cheon Y., Chang L., Chen M., Greenstein D., Wohltmann M., Turk J., Rapoport S.I. Imaging decreased brain docosahexaenoic acid metabolism and signaling in iPLA(2)beta (VIA)-deficient mice. J. Lipid Res. 2010, 51:3166-3173.
77. Y. Cheon, H.W. Kim, M. Igarashi, H. Modi, L. Chang, K. Ma, D. Greenstein, M. Wohltmanmn, J. Turk, S.I. Rapoport, A.Y. Taha, Disturbed brain phospholipid and docosahexaenoic acid metabolism in calcium-independent phospholipase A2-VIA (iPLA2Β)-knockout mice, (Submitted for publication).
78. Contreras M.A., Greiner R.S., Chang M.C., Myers C.S., Salem N., Rapoport S.I. Nutritional deprivation of alpha-linolenic acid decreases but does not abolish turnover and availability of unacylated docosahexaenoic acid and docosahexaenoyl-CoA in rat brain. J. Neurochem. 2000, 75:2392-2400.
79. 11C]-arachidonate in normocapnic and hypercapnic monkeys, measured with positron emission tomography. Brain Res. 1997, 755:74-83.
80. Esposito G., Giovacchini G., Liow J.S., Bhattacharjee A.K., Greenstein D., Schapiro M., Hallett M., Herscovitch P., Eckelman W.C., Carson R.E., Rapoport S.I. Imaging neuroinflammation in Alzheimer's disease with radiolabeled arachidonic acid and PET. J. Nucl. Med. 2008, 49:1414-1421.
81. Channing M.A., Simpson N. Radiosynthesis of 1-[11C]polyhomoallylic fatty acids. J. Labeled Comp. Radiopharmacol 1993, 33:541-546.